Skip to main content

Roche to Distribute Aclara s Arteas LabCards

NEW YORK, Nov. 7 – Aclara BioSciences said Wednesday that Roche Applied Science had agreed to market its Arteas LabCard product, which is designed to allow researchers to run assays using small amounts of consumables. 

Roche Applied Science, a business unit of Roche Diagnostics, will begin launching the Arteas product in the first quarter of next year. Until then, Aclara will continue selling its LabCards. 

Roche has also obtained rights to negotiate to market additional Aclara products.

"After a thorough evaluation, we concluded that ACLARA possessed an unusual combination of strengths in both microfluidics and application chemistries, which together solve important customer needs,” Juergen Flach, general manager of Roche Diagnostics Corporation, said in a statement. 

Aclara said that LabCard require 10 – 100 times less consumables than conventional microwell plates.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.